These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29423660)

  • 1. Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity.
    Yu C; An M; Jones E; Liu H
    Pharm Res; 2018 Feb; 35(3):56. PubMed ID: 29423660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    Yu C; An M; Li M; Liu H
    Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.
    Wingender G; Garbi N; Schumak B; Jüngerkes F; Endl E; von Bubnoff D; Steitz J; Striegler J; Moldenhauer G; Tüting T; Heit A; Huster KM; Takikawa O; Akira S; Busch DH; Wagner H; Hämmerling GJ; Knolle PA; Limmer A
    Eur J Immunol; 2006 Jan; 36(1):12-20. PubMed ID: 16323249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes.
    Nakagawa T; Tanino T; Onishi M; Tofukuji S; Kanazawa T; Ishioka Y; Itoh T; Kugimiya A; Katayama K; Yamamoto T; Nagira M; Ishii KJ
    Front Immunol; 2021; 12():803090. PubMed ID: 35003132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity.
    Peter M; Bode K; Lipford GB; Eberle F; Heeg K; Dalpke AH
    Immunology; 2008 Jan; 123(1):118-28. PubMed ID: 17961163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Delivery of Immunostimulatory CpG Oligodeoxynucleotides to Antigen-Presenting Cells in Draining Lymph Nodes by Stearic Acid Modification and Nanostructurization.
    Nagaoka M; Liao W; Kusamori K; Nishikawa M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides.
    Inoue J; Aramaki Y
    Vaccine; 2007 Jan; 25(6):1007-13. PubMed ID: 17049678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles.
    Wilson KD; Raney SG; Sekirov L; Chikh G; deJong SD; Cullis PR; Tam YK
    Int Immunopharmacol; 2007 Aug; 7(8):1064-75. PubMed ID: 17570323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic stimulation of antigen presenting cells via TLR by combining CpG ODN and poly(γ-glutamic acid)-based nanoparticles as vaccine adjuvants.
    Shima F; Uto T; Akagi T; Akashi M
    Bioconjug Chem; 2013 Jun; 24(6):926-33. PubMed ID: 23631730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation.
    Liu W; Yang X; Wang N; Fan S; Zhu Y; Zheng X; Li Y
    Mediators Inflamm; 2017; 2017():6541729. PubMed ID: 28539706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine.
    He LZ; Weidlick J; Sisson C; Marsh HC; Keler T
    Cell Mol Immunol; 2015 Nov; 12(6):719-28. PubMed ID: 25345808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CpG Adjuvant to Lymph Node via Dextran Conjugate Enhances Antitumor Immunotherapy.
    Zhang W; An M; Xi J; Liu H
    Bioconjug Chem; 2017 Jul; 28(7):1993-2000. PubMed ID: 28644608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune responses induced by classes of CpG oligodeoxynucleotides in ovine lymph node and blood mononuclear cells.
    Booth JS; Nichani AK; Benjamin P; Dar A; Krieg AM; Babiuk LA; Mutwiri GK
    Vet Immunol Immunopathol; 2007 Jan; 115(1-2):24-34. PubMed ID: 17067685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic oligonucleotides as modulators of inflammation.
    Klinman D; Shirota H; Tross D; Sato T; Klaschik S
    J Leukoc Biol; 2008 Oct; 84(4):958-64. PubMed ID: 18430787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development.
    Bayyurt B; Tincer G; Almacioglu K; Alpdundar E; Gursel M; Gursel I
    J Control Release; 2017 Feb; 247():134-144. PubMed ID: 28069554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of CpG-induced immune activation by suppressive oligodeoxynucleotides.
    Klinman DM; Zeuner R; Yamada H; Gursel M; Currie D; Gursel I
    Ann N Y Acad Sci; 2003 Dec; 1002():112-23. PubMed ID: 14751829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal role of ADP-ribosylation factor 6 in Toll-like receptor 9-mediated immune signaling.
    Wu JY; Kuo CC
    J Biol Chem; 2012 Feb; 287(6):4323-34. PubMed ID: 22170068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG-PEG Conjugates and their Immune Modulating Effects after Systemic Administration.
    Wu C; Xiang X; Yue Y; Li L; Li Y; Zhang C; Xu Y
    Pharm Res; 2018 Mar; 35(4):80. PubMed ID: 29500548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue.
    Corogeanu D; Zaki K; Beavil AJ; Arnold JN; Diebold SS
    PLoS One; 2023; 18(3):e0282831. PubMed ID: 36913398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.